Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04621786 · ClinicalTrials.gov registry record · NA
Electroconvulsive Therapy Amplitude Titration
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT04621786 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 41 participants.
The verdict
NCT04621786, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study is focused on advancing ECT treatment for older adults with depressive disorders by refining neuromodulation stimulus parameters to improve efficacy and cognitive safety.
Interventions
- DEVICE Mecta Spectrum 5000Q paired with Soterix Medical 4X1 HD - ECT Multi-Channel Stimulation Interface
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04621786
The ClinicalTrials.gov registry entry for NCT04621786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mecta Spectrum 5000Q paired with Soterix Medical 4X1 HD - ECT Multi-Channel Stimulation Interface is the first listed.
NCT04621786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04621786 about?
NCT04621786 is a clinical study titled "Electroconvulsive Therapy Amplitude Titration". This study is focused on advancing ECT treatment for older adults with depressive disorders by refining neuromodulation stimulus parameters to improve efficacy and cognitive safety.
What is the current status of trial NCT04621786?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2021-03-01. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT04621786?
The interventions under investigation include: Mecta Spectrum 5000Q paired with Soterix Medical 4X1 HD - ECT Multi-Channel Stimulation Interface (DEVICE).
Who is sponsoring clinical trial NCT04621786?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.